Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Pancreas in Coronavirus Disease 2019 Infection.

Gastroenterology clinics of North America·2023
Same author

The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?

World journal of emergency surgery : WJES·2022
Same author

Acute pancreatitis and COVID-19: A literature review.

World journal of gastrointestinal surgery·2021
Same author

Incarcerated paraoesophageal hernia complicated with distal oesophageal perforation: a combined laparoscopic and endoscopic approach.

BMJ case reports·2021
Same author

Jejunal intussusceptions due to metastatic malignant melanoma: a case report.

Journal of surgical case reports·2021
Same author

Laparoscopic Resection of a Splenic Artery Aneurism with Spleen Preservation.

Case reports in surgery·2020

相关实验视频

Updated: Jan 17, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

648

预测可切除直肠癌的早期复发情况.

Manuel Carmo Silva1, Tiago Correia de Sá2, Kayla P Pereira3

  • 1Department of Radiotherapy, ULS Santa Maria, Lisbon 1649-028, Portugal. mj.oliveiracampos@gmail.com.

World journal of gastrointestinal surgery
|September 15, 2025
PubMed
概括

在直肠癌 (RC) 中,早期复发 (ER) 可以使用8个月的无复发生存截止期来确定. 这一发现有助于完善高风险患者的监测,改善生存结果.

关键词:
先进的成像成像技术已经得到了发展.化学疗法或放射疗法早期的复发 早期的复发分子生物标志物 分子生物标志物没有复发的生存率.可以切除的直肠癌.

更多相关视频

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

493
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

1.4K

相关实验视频

Last Updated: Jan 17, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

648
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

493
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

1.4K

科学领域:

  • 在瘤学瘤学.
  • 手术瘤学手术瘤学
  • 临床研究 临床研究

背景情况:

  • 早期复发 (ER) 是直肠癌 (RC) 管理中的一个重要问题.
  • 目前的监测策略可能无法最佳地检测ER,影响患者的存活率.
  • 新辅助化学放射治疗 (CRT) 可以减少局部区域性复发,但可能无法消除ER风险.

研究的目的:

  • 分析最近关于可切除RC的ER的发现.
  • 评估8个月无复发生存 (RFS) 截止值对区分ER的有用性.
  • 讨论对RC的监测和治疗策略的影响.

主要方法:

  • 编辑审查RC中ER的最新发现.
  • 专注于一项研究,该研究确定了ER检测的8个月RFS截止时间.
  • 分析CRT对ER和复发模式的影响.

主要成果:

  • 八个月的RFS切断有效地区分ER与RC的晚期复发.
  • 这种切断对复发后的生存率和整体生存率有影响.
  • 虽然CRT有效防止局部或区域性复发,但并不能完全减轻ER风险.

结论:

  • 个性化风险评估和密集的术后监测,特别是在第一年,对于在RC中管理ER至关重要.
  • 8个月的RFS截止时间为加强高风险患者的监测提供了宝贵的时间框架.
  • 未来的研究应该涉及使用先进生物标志物的多中心研究,以改善ER预测和管理.